Like a Rock | The Daily Peel | 9/26/22

Silver Banana goes to...

Market Snapshot

You know it’s bad when the WSJ starts putting falling stock indices on their home page.

JPow’s comments during the September FOMC were even more hawkish than expected. It felt like last week was when the market really started to take him seriously.

The dollar’s been continuing its climb along with bond yields, both of which are at their highest levels since ‘08. Crazy times.

At the close, the Dow plummeted 1.62%, the Nasdaq nosedived 1.80%, and the S&P fell 1.72%.

Take your deal-making to the next level with Caplinked. Whether you’re a mom & pop shop or one of the big boys, our digital data rooms give you the tools and functionality you need to get the deal done, at the right price. Set up your data room today

Let’s get into it.

Monkey Meme of the day

Source

Banana Bits

Banana Brain Teaser

Macro Monkey Says

Bankers are old school. Deal-making shouldn’t be.

What's Ripe

CBOE Volatility (VIX) — Conventional wisdom on The Street states that a bear market is usually paired with a spike in the VIX.

Historically, that relationship has been pretty solid, but this year has investors scratching their heads.

Despite carnage across the board, the fear gauge has been more subdued than expected.

That trend was bucked Friday as the VIX shot upwards. TBD if it will continue.

At the end of the session, VIX was up 10.02%.

Evaxion Biotech ($EVAX) — Skin cancer is the most common form of cancer in the U.S., and melanoma is the most deadly form.

Evaxion is a Danish company working on personalized treatments for melanoma, and it just enrolled its first patient in a new clinical trial, marking a critical milestone.

If the trial shows promising results, this tiny player could catapult itself into a multi-billion dollar giant in the huge market for skin cancer treatments globally.

$EVAX was up 20.99% by the end of the day.

What's Rotten

Credit Suisse ($CS) — Not much has gone right for $CS for basically the last decade. Involvement in the 1MDB scandal and Archegos collapse are just a few of the big controversies they’ve been linked to.

It’s struggled to compete amid all these issues, and there are rumors that its investment bank may be looking to exit the U.S. market.

A funding gap is also forcing it to look for new capital. Just a lot of bad vibes that sent the stock plummeting Friday.

$CS closed the day down 12.10%.

Carnival ($CCL) — The cruise operator is set to report earnings at the end of the month, and investors aren’t expecting good news.

Travel stocks broadly got hammered after this week’s 75 bps rate hike and associated comments from the Fed. It’s no secret that recessions hit leisure companies especially hard.

To add to the woes, Carnival took on a sh*t ton of debt during the pandemic just to stay alive, and higher rates means higher debt service payments, further eating into revenues.

By the end of the day, $CCL was down 7.16%.

Thought Banana

Thatchernomics Part 2 — In the span of just a few weeks, an entirely new leadership regime took hold in the U.K., and they’re making bold changes that could either ignite a new era of British competitiveness or sink the economy further into a hole.

• Liz Truss is hoping that her medicine of lower taxes and deregulation will unleash growth, following the Thatcher/Reagan model.
• Investors aren’t optimistic. Stocks, bonds, and the pound all fell through the floor on the announcement.
• The tax cuts come just a few weeks after promising the government would take the brunt of the pain from higher energy prices.
• Running up its credit card balance could be a risky move, especially since rising rates = higher debt service payments.

Many economists point to lagging productivity as the root cause of the U.K.’s economic problems recently.

If Liz Truss and team can unlock productivity growth, it could change Britain’s near-term fortunes.

Wise Investor Says